ClinicalTrials.Veeva

Menu

Behavioral Self-activation and Virtual Reality in Depression (DEPREVACT)

University Hospital Center (CHU) logo

University Hospital Center (CHU)

Status

Enrolling

Conditions

Depression

Treatments

Other: Efficacy of Behavioral Self-Activation without virtual reality
Other: Efficacy of Behavioral Self-Activation with virtual reality

Study type

Interventional

Funder types

Other

Identifiers

NCT03621488
RECHMPL17_0215

Details and patient eligibility

About

Depression is a major handicap in daily life and is often treated by behavioral activation (CA), including the Brief Behavioral Activation Treatment for Depression (BATD).The CA principle is to set up activities, in keeping with the values of the individual. Other tools associated with the CA deserve to be explored as virtual reality (VR), which offers scenarios and sensations similar to real life and a sense of life. in a safe and controlled environment, with the support of the therapist.The main objective is to compare the effectiveness of the program "BATD with RV" versus "BATD without RV" on the intensity of the depressive symptomatology and CA in everyday life.

Methodology: This is a randomized, blinded study. Inclusion criteria are: 18 to 70 years old; unipolar depression diagnosis; Showing a score of ≥ 17 on the BDI-II. 80 subjects will be recruited over 24 months and randomized into 2 groups: 1) intervention group program BATD in VR; 2) BATD program intervention group without RV, lasting 45 minutes.

Judgment Criteria: The effectiveness of the intervention will be evaluated by the BDI-II scale and the Behavioral Activation for Depression Scale (BADS).

Outcomes: A new management of depression (AC with RV) to improve the quality of life of the patient; proof of its effectiveness; a generalization of this care; and recognition of its effectiveness in the scientific community.

Enrollment

80 estimated patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Adults aged 18 to 70,
  2. Having a diagnosis of unipolar depressive disorder characterized (diagnostic criteria of depression of DSM-V),
  3. Primary depression and not secondary to another disorder (eg social phobia, OCD, severe personality disorder, ASD, TCA, ect.)
  4. Showing a score greater than or equal to 17 points on the IDB-II,
  5. Followed by a psychiatrist from the University Hospital of Montpellier or a liberal,
  6. Can read, understand and speak French,
  7. To be affiliated or beneficiary of a social security scheme.
  8. Collection of informed consent.

Exclusion criteria

(1) History of head trauma or recent central neurological conditions only (2) Current treatment by seismotherapy or rTMS or CBT. (3) Exclusion from all substance-related disorders except tobacco-related disorder (DSM-V)

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

80 participants in 2 patient groups

Efficacy of Behavioral Self-Activation with virtual reality
Experimental group
Description:
10 individual sessions of the Brief Behavioral Activation Treatment for Depression (BATD) program, lasting one hour, at the start of treatment, then half an hour thereafter, once a week + virtual reality activities of the session 4 to 9 lasting half an hour.
Treatment:
Other: Efficacy of Behavioral Self-Activation with virtual reality
Efficacy of Behavioral Self-Activation without virtual reality
Sham Comparator group
Description:
10 individual sessions of the Brief Behavioral Activation Treatment for Depression (BATD) program, lasting one hour, at the start of treatment, then half an hour thereafter, once a week.
Treatment:
Other: Efficacy of Behavioral Self-Activation without virtual reality

Trial contacts and locations

1

Loading...

Central trial contact

Alexandre DE CONNOR

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems